Attachment 2 Domain 2 sample RFTOP .pdf

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

DOMAIN 2- Sample RFTOP

RFTOP Title: Implement and evaluate a targeted use of gown and gloves to assess effectiveness at preventing transmission of pathogens

Multiple task orders may be awarded subject to availability of funds and contractors should prepare technical proposals that are priced in the range of 650,000.00 - $950,000.00 in order to be considered for award.

PROPOSED PERIOD OF PERFORMANCE: Work shall begin from date of award of the task order and shall continue for a period of 18 months. This project is a non-severable and will be funded fully at the time of award.

Multiple task orders may be awarded under this RFTOP.

PROPOSAL PREPARATION AND SUBMISSION

1. General Instructions: Offeror(s) shall submit proposals consisting of the following volumes:

Technical Proposal – Volume I Business Proposal – Volume II

a. Technical Proposal-Volume I

Technical Proposal Preparation Instructions – Page limit is (10) single-spaced pages of text for the technical proposal; (the page limit does not include appendices or resumes). Each volume in the proposal shall include a copy of the cover letter (letter of transmittal), title page and table of contents. The table of contents shall list sections, subsections and page numbers.

The technical proposal should be in as much detail as you consider necessary to reflect a clear understanding of the nature of the work being undertaken.

The technical proposal must NOT contain reference to cost; however, resource information, such as data concerning labor hours and categories, material, subcontracts, etc., must be contained in the technical proposal so that your understanding of the statement of work can be evaluated.

b. Business Proposal-Volume II

Pricing Narrative: The Offeror shall provide an explanation and/or detailed information on how the fully loaded labor rates were derived. The business proposal shall be an Excel spreadsheet, with an itemized price breakout per task for each period (e.g. Base Year, Option Years), including itemized prices for any subcontracted work. Proposed labor hours, labor costs, travel and other direct costs for this task order request shall be organized around the tasks and related deliverables described herein.

Pricing Worksheet: Utilizing the format in Attachment 11 of RFP, provide all applicable labor categories, descriptions, and rates, travel for the Prime Contractor/Subcontractor for each period (e.g. Base Year, Option Years). Please return Section B (CLIN and payment milestone) with Business Proposal.

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

SECTION B SUPPLIES OR SERVICES AND PRICES/COSTS

BASE PERIOD

ITEM SUPPLIES / SERVICES QTY / UNIT UNIT

PRICE

EXTENDED

PRICES

0001 Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program 2021 Domain 2 Implement and evaluate a targeted use of gown and gloves to assess effectiveness at preventing transmission of pathogens

POP: 18 months from award This is a Firm-Fixed Price and Non-Severable Line Item

1 Job $________ $ ___________

**The offeror requires to identify the zip code of the work site so the appropriate wage determination can be identified and included with an awarded task order.

B.1 PAYMENT TERMS

Payment will be made subject to receipt of deliverables in accordance with the payment schedule established herein and in accordance with FAR 52.232-25. Prompt Payment, which states that the due date for making invoice payments shall be the 30th day after the designated billing office (see block 21 of the order) has received a proper invoice from the vendor or the 30th day after Government acceptance of the services provided by the vendor, whichever is later.

B.2 Schedule of Milestones for Performance-Based Payments In accordance with FAR 52.232-32, PERFORMANCE BASED PAYMENTS (April 2012), upon successful completion of an event, the contractor may request performance based payments. The determination of eligibility for receipt of payment will be made by the Contracting Officer upon written certification from the Contracting Officer’s Representative (COR) that the performance milestone has been met. It is anticipated that each milestone payment will approximate the estimated timeline listed below but variation is anticipated and eligibility for payment could occur sooner or later depending upon the time of completion of the designated milestone.

Milestone payments are subject to the terms of FAR 52.232-32 incorporated in this contract.

The COR receiving and acceptance of monthly performance based payments is based on verification that work on the contract was satisfactorily performed during the month and that, at a minimum, the following activities were satisfactorily performed.

Milestone Payment Schedule

CONTRACTOR PROPOSED

MILESTONE EVENT PAYMENT %* DOLLAR AMOUNT

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

TOTAL 100 % $

*Milestone event payments may be allocated on a periodic basis as long as a completed event is associated with that payment.

SAMPLE PAYMENT SCHEDULE for this task order

Deliverable Invoice Due Date Payment Once Approved by COR

Task 1: Quarterly Reports Due at end of months 3, 6, 9, 12, and 15. 5% of award per report, total of 25%

Task 2: Identifying, recruiting, and enrolling the facilities

Via email to COR and Science Officer within 5 months of base period award.

5% of award

Task 3: Obtain and appropriate IRB/Human Subjects approvals for the project

Via email to COR and Science Officer when received, within 3 months after award.

10% of award

Task 5: Training materials finalized Via email to COR and Science Officer, prior to month 6

10% of award

Task 12: Assessment of outcomes of intervention in selected facilities

12 months after award (Group 1 NHs)

15 months after award (Group 2 NHs)

10% of award each, total of 20%

Task 13: Final Report 17 months after award (draft)

18 months after award (final)

10% of award each, total of 20%

Task 14: Final base period project meeting

18 months after award 10% of award

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

PERFORMANCE-BASED WORK STATEMENT

OVERVIEW

The Centers for Disease Control and Prevention’s (CDC) Prevention and Response Branch has responsibility for defining evidence-based infection control recommendations in various patient and out-patient care facilities throughout the United States, including U.S. territories. Particularly given high rates of infection transmission in the specific settings of high transmission and new concerns based on COVID-19 outbreaks/hotspots, the Prevention and Response Branch is interested in sustainable and affordable methods to decrease infection transmission. Outcomes could further be helpful in understanding how best to use PPE when volumes are limited.

CDC is engaged in a number of initiatives aimed at improving infection control practices in many settings.

CDC has recently released guidance recommending the use of gown and gloves for high-contact nursing home resident care activities when novel or targeted Staphylococcus aureus (SA), both methicillin-resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA), and multidrug-resistant Gram-negative bacteria have been identified. A recent pilot in two community nursing homes has shown support for the targeted use of gown and gloves for the prevention of SA transmission among short-stay residents.

CDC is interested in seeing this same intervention in other areas of interest or specific areas of interest like ventilator units, dialysis facilities, and others. Given the unique care needs and high-risk nature of residents in some of these specific areas, an evaluation of the targeted use of gown and gloves to prevent transmission of pathogens, including antibiotic resistant organisms, within these settings is highly necessary. This project addresses several CDC research and program priorities including 1) reducing spread of antibiotic resistant pathogens in healthcare, 2) preventing invasive Staphylococcus aureus and multidrug-resistant Gram-negative bacterial infections among a high-risk, vulnerable population, and 3) improving patient/resident health and wellness. Findings from this task order will expand the evidence base for MDRO prevention in specific settings and inform the development of CDC/DHQP guidelines for this setting.

PROJECT GOALS

The goal of this task order is to demonstrate the feasibility, acceptability, and utility of a using a targeted gown and glove use approach within a specific setting (e.g. ventilator units in nursing homes) to prevent SA and Carbapenem-resistant Gram-negative bacteria acquisition and infection. The intervention will include gown and glove use for high risk care of high risk patients or residents based on prior research showing the increased risk of transmission from patients or residents to healthcare workers’ (HCWs) hands and clothing associated with certain care activities. High risk individuals may be immune compromised or those having either an indwelling medical device (e.g., urinary catheter, feeding tube, tracheostomy tube, central line) or wound. Rather than wearing gowns and gloves for all care activities to prevent transmission (as would be indicated for Contact Precautions), gown and glove use is targeted to high-risk resident care activities, including: dressing, bathing, transferring, providing hygiene, changing linens, changing briefs or assisting with toileting, device care or use of a device (central line, urinary catheter, feeding tube, tracheostomy), and wound care (any skin opening requiring a dressing, or dialysis intervention. The vendor shall consider all published prior studies and human factors engineering concepts when working with each facility to select gowns and gloves, personal protective equipment (PPE) storage options, and development of signage for identifying patients/residents that will require the use of gowns and gloves for high-risk care.

CDC is requesting proposals in which the Contractor can show plan to:

• Identify the feasibility of the intervention. Feasibility success will be judged by the adherence of >80% with targeted gown and glove use, and the sustained implementation of the intervention component for 3 months.

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

• Identify the acceptability of the intervention. Acceptability will be determined qualitatively by identifying barriers to implementation by communicating with appropriate stakeholders such as front-line staff, administrators, or owners, depending on the facility. Elements found to be infeasible or unacceptable will be modified to allow for development of an implementation guide and relevant education.

• Determine transmission and acquisition rates of Staphylococcus aureus (SA), both methicillin-resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA), and multidrug-resistant Gram-negative bacteria (specifically Carbapenem-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumanii, further referred to as Carbapenem-resistant Gram-negative bacteria (CR-GNB)) comparing post- to pre-intervention.

Each facility shall act as their own control, via direct comparison of each facility during the intervention to itself during the baseline period, reducing variability.

SCOPE OF WORK

This study shall determine the feasibility and acceptability of using the targeted use of gowns and gloves based on patient or resident risk factors during high-risk care activities at preventing new acquisition of SA and CR-GNB in hopes that increasing the use of gown and gloves for high-risk care activities with invasive medical devices and wounds or with dialysis equipment, etc. shall decrease the transmission of SA and CR-GNB by reducing the healthcare worker cross-contamination. This study will also estimate the impact of the intervention by comparing post- to pre-intervention transmission and acquisition rates of SA, both MRSA and MSSA, and multidrug-resistant Gram-negative bacteria.

Aim 1a: To assess the feasibility of using a targeted gown and glove approach to preventing the spread of MDROs within the facility selected by the following criteria:

a) Recruitment of at least 2 at risk facilities/sites

b) Adherence of >80% with targeted gown and glove use; and

c) Sustained implementation of the intervention component for 3 months

Aim 1b: Develop an implementation guide for the targeted gown and glove approach to preventing the spread of MDROs within selected area influenced by a qualitative examination of the acceptability of and any barriers to implementation using conversational and open-ended (non-structured) interviews with stakeholders (e.g., front-line staff, administrators, owners)

Aim 2: Estimate the impact of the intervention through comparing post- to pre-intervention transmission and acquisition rates of Staphylococcus aureus (SA), both methicillin-resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA), and multidrug-resistant Gram-negative bacteria (specifically Carbapenem-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumanii

(CR-GNB))

The vendor shall be responsible for developing institutional review board (IRB) protocols and obtaining and maintaining all necessary local IRB approvals to fulfill the project objectives. The contractor shall be responsible for maintaining data, obtain and perform laboratory testing, and performing analysis of both the evaluation of SA and C-GNB acquisition rates and adherence to gown and glove use.

TASKS TO BE PERFORMED

The contractor shall provide all labor, expertise, materials, and supplies as well as perform all services required to carry out the work under this contract.

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

Task 1: Start Up Meeting and Communication

1. The contractor shall attend an initial teleconference meeting with the COR and other relevant scientific staff within two weeks of the effective date of the task order. The purpose of the meeting shall be to review and clarify the scope of work and delivery schedule for tasks and to establish communication protocols. During the meeting, each task and deliverable shall be reviewed.

2. The contractor shall coordinate all project related communications with the COR and CDC Science Officer. The contractor shall maintain regular communications with the CDC throughout the project. The chief means of communication shall be via conference calls that shall be scheduled every month throughout the project period required to complete the project. Weekly calls may be scheduled as work planning and progress requires and as determined by the COR.

The contractor shall respond to all emails and telephone communications from the Science Officer within 3 working days.

3. The contractor shall submit a quarterly report (every three months) to the CDC throughout the course of the work detailing status, processes and outcomes, challenges, and all relevant considerations for upcoming work.

Task 2: Identifying, recruiting, and enrolling the facilities

1. The contractor shall identify at least 2 facilities to participate in the cluster-randomized study with cross-over design including a baseline period.

a) The contractor must be able to gain access to medical records, the intervention unit for observations, and intervention unit staff for trainings, at each of the enrolled facilities.

b) The contractor must keep routine communication with chosen facilities including collaborative calls, learning sessions, and overview of outcomes at the end of the study.

c) Sites should be selected in coordination with the CDC Science Officer and/or COR. Sites should not be finalized without CDC concurrence.

d) The contractor shall provide to the CDC Science Officer the characteristics of included facilities, including but not limited to:

1. Facility capacity, census, number of units and/or number of beds on each unit

2. Location

3. Specialty services offered at facility (if any)

4. for-profit vs. not-for-profit status

5. CMS and state certification/licensing status

6. Affiliation (independent/free-standing, multi-facility organization (chain), hospital system (attached vs. free-standing), other)

7. Number of patients or residents per room on intervention unit, etc.

8. Any other relevant information useful for consideration of facility type

Task 3: Develop and maintain appropriate IRB/Human Subjects for the project

1. The contractor shall develop a protocol(s) to be submitted to the vendor’s and/or enrolled facilities’ Institutional Review Board (IRB).

a) The contractor shall submit the protocol(s) for review to the COR prior to IRB submission.

b) The protocol shall include data collection forms and other tools for the project.

c) The protocol shall include an analytic plan for monitoring outcomes and process measures during the study period.

2. Obtain and maintain IRB approval for the duration of the project.

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

a) The contractor shall obtain, maintain, and renew all needed local IRB approvals and/or exemptions for the duration of the project.

b) Any modifications to the protocol required by IRB should be reviewed by the CDC Science Officer.

c) The contractor shall provide the CDC Science Officer and COR with all documentation of IRB approvals and/or exemptions.

d) The contractor shall prepare and submit any needed protocol modifications or amendments for IRB approval throughout the duration of the project.

Task 4: Initial Baseline period in Selected Facilities

1. Both facilities shall participate in an initial baseline period during which the preparation for intervention (task 6) begins and baseline observations of gown and glove use as well as surveillance cultures for SA (MRSA and MSSA) and C-GNB (including Carbapenem-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumanii) are obtained (task 8).

The baseline period shall last for at least 3 months.

2. The contractor shall train select healthcare workers (HCW) on how to appropriately educate, consent, and obtain swabs for culture from patients or residents. HCW shall also be trained by vendor at start of the study and again as/if needed throughout the study should questions or issue arise or should new HCW staff become involved.

3. Contractor shall measure baseline SA (MRSA and MSSA) and C-GNB (including Carbapenem-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumanii) acquisition by obtaining nasal and inguinal/perineal fold surveillance cultures from patients or residents at the start and end of the baseline period as well as at each admission and discharge throughout the baseline period.

4. Review of medical records shall also occur by contractor weekly in order to identify the high-risk patients or residents for making gown and glove use observations.

5. A member of the study team should conduct direct observations of HCW use of gowns and gloves for patients or residents with wounds and/or devices, etc. (as the baseline for comparison to the intervention data that shall be collected in Task 6). Weekly observations by the study team of high risk care interactions shall be performed for 5-10 high-risk patients or residents (at least one day weekly or as needed to complete expected observations). Data must be recorded and progress towards observation goals should be communicated on routine calls.

Task 5: Training and Preparation for Intervention in Selected Facilities

1. The contractor shall use a participatory approach and human factors engineering concepts to work with each individual facility to select gowns and gloves, personal protective equipment (PPE) storage, and develop signage for identifying patients or residents that shall require the use of gowns and gloves for high-risk care. These signs can be unique to the facility or based on templates, but must list the high-risk patient/resident care activities: dressing, bathing, transferring, providing hygiene, changing linens, changing briefs or assisting with toileting, device care or use of a device (central line, urinary catheter, feeding tube, tracheostomy), dialysis, wound care (any skin opening requiring a dressing), etc. Supplies for the intervention period shall be obtained by the contractor during the training period and delivered to the intervention facility in advance of the intervention.

2. The contractor shall identify 2-3 HCWs (e.g. 2 nursing assistants, 1 nurse) from each facility to be liaisons to the research team. Vendor shall provide one trainer with infection control certification to work closely with HCWs from each NH for the infection prevention training and as needed (see item 6). Any alternative setup will need to be discussed and approved by CDC prior to implementation.

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

3. The contractor shall ensure that HCW are trained on obtaining and preparing swabs for culture remain available at NH or shall identify and train additional HCW on how to appropriately educate, consent, and obtain swabs for culture from patients or residents, as well as label and package swabs.

4. Contractor shall select appropriate NH staff and provide education on how to identify high-risk patients or residents who shall require gown and glove use for high-risk care activities.

5. Training material shall be developed by vendor for the purpose of educating staff on the high-risk activity types. Instructional fliers and study goals shall be reviewed by CDC prior to training. All finalized training materials shall be delivered to CDC prior to engagement. If changes are made, finalized materials shall be provided to CDC at study end.

6. A certified infection preventionist shall train identified workers in each facility holding didactic sessions including demonstration of gloves and gown donning and doffing using the study caddie and signage, and appropriate hand hygiene.

7. Routine and recurring training shall be done such that HCWs will be observed during routine care in an intermittent fashion in order to estimate gown and glove use and ensure this is done according to protocol. If needed, training may be necessary in an interim fashion through the intervention.

Task 6: Intervention in Selected Facilities

1. Vendor shall implement the intervention in the facilities using signage identified during the training period to remind staff of the need for gown and glove use during high-risk patients or resident care activities.

2. Vendor shall also conduct direct observations of HCW use of gowns and gloves for patients or residents.

3. Review of medical records shall also occur by vendor weekly in order to ensure that HCWs are appropriately identifying high-risk individuals, placing study signage, and initiating the intervention of targeted gown and gloves use.

Task 7: Extended Baseline and Cross-over Baseline in Selected Facilities

1. Vendor shall assess adherence in gown and glove use and compare between baseline and intervention periods for all facilities.

Task 8: Obtain nasal and inguinal specimens

1. Contractor shall collect nares and inguinal/perineal fold swabs from all patients/residents residing on the intervention unit at the start of each study period, at new admission, at discharge, and at the end of each study period.

Task 9: Culture and WGS of nasal and inguinal specimens

1. Vendor shall be responsible for obtaining, storing, culturing, and saving inguinal/perineal fold and nasal specimens through the study period and until the analysis is complete and final data is presented to CDC.

2. Whole genome extraction and sequencing will be performed for all positive SA and C-GNB specimens to determine relatedness and new acquisition.

Task 10: Data collection, handling, and storage

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

1. Vendor shall be responsible for the collection, handling and storage of all data. Patient/Resident or facility-identifying data shall not be given to CDC. See section on data management below.

2. A unique identifier shall be assigned to each participant, which shall also be used for labeling all culture specimens and bacterial isolates.

Task 11: Analyze data

1. Once all data are collected and cleaned, they shall be analyzed by the vendor. Patient, resident or facility-identifying data shall not be sent to CDC.

2. For objective 1, the rates of acquisition shall be estimated and compared between the baseline and intervention periods.

3. For objective 3, glove and gown use as well as SA and for C-GNB transmission rates shall be compared between the initial baseline period and the cross-over baseline period in order to determine if the cross-over baseline period is comparable to the initial baseline period. Feasibility, acceptability, and weaknesses shall be evaluated, identified, and described.

Task 12: Assess Outcomes of Intervention in Selected Facilities

1. The contractor shall report process and outcome measurements weekly or more frequently throughout the Intervention period.

a) Outcome 1: The primary outcome shall be a change in SA and in C-GNB acquisition rates comparing baseline and intervention periods.

b) Outcome 2: Compliance with each component of the intervention (

c) Outcome 3: Acceptance, feasibility, and weaknesses of intervention shall be assessed.

2. Status of process and outcome measures should be included in the quarterly reports submitted, and progress toward all metrics and goals should be communicated on routine calls.

Task 13: Final Report

1. The contractor shall submit a final report (in lieu of the final quarterly report) detailing project outcomes to CDC including all associated variables, facilities chosen, activities conducted, and results or efficacy and feasibility of the intervention. Can be via webinar and conducted remotely.

2. Report should detail all work conducted..

3. Report shall include with it any and all materials that were developed as part of the tasks or as part of the intervention training.

4. Report shall include lessons learned and recommendations for future efforts.

Task 14: Final Base Period Project Meeting

1. The contractor shall deliver a final presentation via teleconference on the final project to the CDC

Technical Lead and other relevant staff upon study completion.

The Government will not provide any hardware or software or equipment/supplies for this project. No Government furnished property will be supplied to the contractor.

DELIVERABLES SUMMARY TABLE/REPORTING SCHEDULE

The following deliverables shall be provided to the Contracting Officer Representative (COR) and Science Officer

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

no later than the dates specified below:

The following deliverables shall be provided to the COR/Science Officer no later than the dates specified below:

Task Task Description Deliverable Quantity/

Frequency Due Date

1 Initial planning meeting with appropriate COR

Attendance; COR will arrange 1 Within 2 weeks of task order award

1 Maintain communication with COR

Attendance at scheduled conference calls, response to emails and telephone communications

Ongoing, Monthly

Responses to emails and calls within 2-3 business days.

1 Quarterly Reports Microsoft Word (DOC) format quarterly report including identified items from tasks including: status, recruitments, plans, issues encountered, challenges or concerns, outcome measures and process measurements (when available), and attach all developed tools to date.

5 / submitted every three months

Due at end of months 3, 6, 9, 12, and 15.

2 Identifying, recruiting, and enrolling the facilities

Provide confirmation of 2 study NHs and Summary of NH characteristics as described in Task 2 in Microsoft Word (DOC), Excel (XLSX) or Acrobat (PDF) format.

Via email to COR and Science Officer within 5 months of base period award.

3 Obtain appropriate IRB/Human Subjects approvals for the project

IRB/Human subjects approval(s)/exemptions for study

At least 1 or proof of exempt status or approval, renewals are required in advance of expiration

Via email to COR and Science Officer when received, within 3 months after award.

5 Training and Preparation for Intervention

Develop Training materials – materials developed owned by CDC post-award

Develop signage

Report total number of staff trained

1 sign per facility

1 summary report per facility

8 months after award

9 months after award

12 months after award

Group 1 at 9 months, group 2 at 12 months after award

12 Assess outcomes of intervention in selected facilities

Outcome 1: Comparison of different in SA and C-GNB acquisition rates between

Group 1:

prelim results

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

OTHER REQUIREMENTS

HHSAR Provision, 352.239-73: Electronic and Information Technology Accessibility Notice

(a) Section 508 of the Rehabilitation Act of 1973 (29 U.S.C. 794d), as amended by the Workforce Investment Act of 1998 and the Architectural and Transportation Barriers Compliance Board Electronic and Information (EIT) Accessibility Standards (36 CFR part 1194), require that when Federal agencies develop, procure, maintain, or use electronic and information technology, Federal employees with disabilities have access to and use of information and data that is comparable to the access and use by Federal employees who are not individuals with disabilities, unless an undue burden would be imposed on the agency. Section 508 also requires that individuals with disabilities, who are members of the public seeking information or services from a Federal agency, have access to and use of information and data that is comparable to that provided to the public who are not individuals with disabilities, unless an undue burden would be imposed on the agency.

(b) Accordingly, any offeror responding to this solicitation must comply with established HHS EIT accessibility standards. Information about Section 508 is available at http://www.hhs.gov/web/508. The complete text of the Section 508 Final Provisions can be accessed at http://www.access-board.gov/sec508/standards.htm.

(c) The Section 508 accessibility standards applicable to this contract are: 1194.

205 WCAG 2.0 Level A & AA Success Criteria 302 Functional Performance Criteria baseline and intervention periods

Outcome 2: Weekly and overall compliance report for identification of high-risk patients or residents and for adherence to gown and glove use

Outcome 3: Acceptance, feasibility

Group 2:

Group 1:

Group 2:

Prelim results

15 months after award

13 Final Report Electronic draft report

Electronic final report, along with data collection tools, relevant data dictionaries, and summary data. Final report will include any thoughts of how introduction of intervention in other areas should be conducted or modified based on these outcomes and use/cost analysis of PPE supplies

1 Draft Project Report

1 Final Project Report

17 months after award

18 months after award

14 Final base period project meeting

Final presentation to CDC technical lead – can be done remotely

1 Final presentation

18 months after award http://www.hhs.gov/web/508 http://www.access-board.gov/sec508/standards.htm

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

502 Inoperability with Assistive Technology 503 Applications 504 Authoring Tools 602 Support Documentation 603 Support Services

In order to facilitate the Government's determination whether proposed EIT supplies meet applicable Section 508 accessibility standards, offerors must submit an HHS Section 508 Product Assessment Template, in accordance with its completion instructions. The purpose of the template is to assist HHS acquisition and program officials in determining whether proposed EIT supplies conform to applicable Section 508 accessibility standards. The template allows offerors or developers to self-evaluate their supplies and documentation detail - whether they conform to a specific Section 508 accessibility standard, and any underway remediation efforts addressing conformance issues. Instructions for preparing the HHS Section 508 Evaluation Template are available under Section 508 policy on the HHS Web site http://hhs.gov/web/508.

In order to facilitate the Government's determination whether proposed EIT services meet applicable Section 508 accessibility standards, offerors must provide enough information to assist the Government in determining that the EIT services conform to Section 508 accessibility standards, including any underway remediation efforts addressing conformance issues.

(d) Respondents to this solicitation must identify any exception to Section 508 requirements. If a offeror claims its supplies or services meet applicable Section 508 accessibility standards, and it is later determined by the Government, i.e., after award of a contract or order, that supplies or services delivered do not conform to the accessibility standards, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its expense.

(e) Electronic content must be accessible to HHS acceptance criteria. Checklist for various formats are available at http://508.hhs.gov/, or from the Section 508 Coordinator listed at https://www.hhs.gov/web/section- 508/additional-resources/section-508-contacts/index.html. Materials that are final items for delivery should be accompanied by the appropriate checklist, except upon approval of the Contracting Officer or Representative.

(End of provision)

GENERAL INFORMATION

A. Place of Performance: The work to be performed under this contract will be performed at the Contractor’s facility and associated academic, healthcare or research facilities as required.

B. Type of Contract: The government will award a Firm-fixed price contract.

C. Contractor Travel: The cost associate with completing the work/task, should be part of the task cost (i.e

CLIN 0001).

D. Confidentiality of Information: Work on this project may require that personnel have access to Privacy Information. Personnel shall adhere to the Privacy act, Title 5 of the U.S. Code, Section 552a and applicable agency rules and regulations. The user agency will identify and provide direction and guidance for safeguarding all information subject to the Privacy Act. Reports and case files containing individual personal information are confidential. The CDC is not authorized to release individual case reports, and access to individual case data is strictly controlled. The contractor personnel are required to work with case records as well as databases. It is a requirement that the data remain in a controlled access environment.

http://hhs.gov/web/508 http://508.hhs.gov/ https://www.hhs.gov/web/section-508/additional-resources/section-508-contacts/index.html https://www.hhs.gov/web/section-508/additional-resources/section-508-contacts/index.html

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

E. Government Furnished Property, Equipment, and Services Not Applicable

Special Clearances:

Check all that apply: Comments

OMB

Human Subjects Privacy Act Appropriate security controls and Rules of Behavior should be incorporated to protect the confidentiality of information, proprietary, sensitive, and Personally Identifiable Information (PII) the Contractor may come in contact with during the performance of this contract.

IT Security IT Contractor performance and resulting deliverables must adhere to all federal, HHS, and/or CDC IT security policies and procedures. Based upon the scope of this contract, the SOW must include the appropriate language to address the following IT security topics:

Standard for Security Configurations; Standard for Encryption Language; and Security requirements for Federal Information technology Resources.

A. Confidentiality of Information: Work on this project may require that personnel have access to Privacy Information. Personnel shall adhere to the Privacy Act, Title 5 of the U.S. Code, Section 552a and applicable agency rules and regulations. The user agency will identify and provide direction and guidance for safeguarding all information subject to the Privacy Act. Reports and case files containing individual personal information are confidential. The CDC is not authorized to release individual case reports, and access to individual case data is strictly controlled. The contractor personnel are required to work with case records as well as databases. It is a requirement that the data remain in a controlled access environment.

B. Section 508 Compliance

By agreeing to the terms of the Safe Healthcare, Epidemiology, and Prevention Research Development (SHEPheRD) Program IDIQ Contract, the offeror must comply with Section 508 standards for all deliverables in this task order. The offeror must complete an HHS/CDC checklist(s) as needed for each deliverable specified.

The applicable Section 508 standards to this task order are 1194.

205 WCAG 2.0 Level A & AA Success Criteria 302 Functional Performance Criteria 502 Inoperability with Assistive Technology 503 Applications 504 Authoring Tools 602 Support Documentation 603 Support Services

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

INVOICING INSTRUCTIONS

Invoice Submission - CDCAG001 – Invoice Submission (Mar 2006)

(a) The Contractor is required to submit the original invoice/voucher directly to the Financial Management Office using one (1) of three (3) methods (but only one method). Invoices shall not be submitted more frequently than one (1) time per month.

(1) By Email: fmoapinv@cdc.gov (the best and preferred method. See paragraph (b).)

(2) By Facsimile: FAX 404-638-5324

(3) By Mail to: The Centers for Disease Control and Prevention Financial Management Office (FMO) P.O. Box 15580 Atlanta, GA 30333

(b) The contractor shall submit the original invoices/vouchers to the CDC FMO, the COR, and the

Contracting Officer (CO). The preferred method for doing so is to simultaneously email electronic files of the invoice and any backup documents to each of the three (3) parties.

(c) The Contractor is , is not required to submit a copy of each invoice directly to the Contracting

Officers Representative concurrently with submission to the Contracting Officer.

(d) In accordance with 5 CFR part 1315 (Prompt Payment Act), CDC's Financial Management Office (FMO) is the designated billing office for the purpose of determining the payment due date under FAR 32.904(b); the controlling “date of receipt” of an invoice is the date on which the FMO receives a proper invoice from the contractor.

(e) The Contractor shall include (as a minimum) the following information on each invoice:

(1) Contractor’s Name & Address

(2) Contractor’s Tax Identification Number (TIN)

(3) Purchase Order/Contract Number and Task Order Number, as appropriate

(4) Invoice Number

(5) Invoice Date

(6) Contract Line Item Number (CLIN) and Description of Item

(7) Quantity

(8) Unit Price & Extended Amount for each line item

(9) Shipping and Payment Terms

(10) Total Amount of Invoice

(11) Name, title and telephone number of person to be notified in the event of a defective invoice

(12) Payment Address, if different from the information in (e) (1).

(13) DUNS + 4 Number

(End of Clause) mailto:FMOAPINV@CDC.GOV

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

TASK ORDER CLAUSES

APPLICABLE FAR CLAUSES:

52.246-7 Inspection of Research and Development—Fixed-Price (Aug 1996) 52.246-9 Inspection of Research and Development (Short Form) (Apr 1984) 52.232-2 Payments under Fixed-Price Research and Development Contracts (Apr 1984)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (Oct 2020)

(a) Definitions. As used in this clause— Backhaul means intermediate links between the core network, or backbone network, and the small subnetworks at the edge of the network (e.g., connecting cell phones/towers to the core telephone network).

Backhaul can be wireless (e.g., microwave) or wired (e.g., fiber optic, coaxial cable, Ethernet).

Covered foreign country means The People’s Republic of China.

Covered telecommunications equipment or services means–

(1) Telecommunications equipment produced by Huawei Technologies Company or ZTE Corporation (or any subsidiary or affiliate of such entities);

(2) For the purpose of public safety, security of Government facilities, physical security surveillance of critical infrastructure, and other national security purposes, video surveillance and telecommunications equipment produced by Hytera Communications Corporation, Hangzhou Hikvision Digital Technology Company, or Dahua Technology Company (or any subsidiary or affiliate of such entities);

(3) Telecommunications or video surveillance services provided by such entities or using such equipment;

or

(4) Telecommunications or video surveillance equipment or services produced or provided by an entity that the Secretary of Defense, in consultation with the Director of National Intelligence or the Director of the Federal Bureau of Investigation, reasonably believes to be an entity owned or controlled by, or otherwise connected to, the government of a covered foreign country.

Critical technology means–

(1) Defense articles or defense services included on the United States Munitions List set forth in the International Traffic in Arms Regulations under subchapter M of chapter I of title 22, Code of Federal Regulations;

(2) Items included on the Commerce Control List set forth in Supplement No. 1 to part 774 of the Export Administration Regulations under subchapter C of chapter VII of title 15, Code of Federal Regulations, and controlled-

(i) Pursuant to multilateral regimes, including for reasons relating to national security, chemical and biological weapons proliferation, nuclear nonproliferation, or missile technology; or

(ii) For reasons relating to regional stability or surreptitious listening;

(3) Specially designed and prepared nuclear equipment, parts and components, materials, software, and technology covered by part 810 of title 10, Code of Federal Regulations (relating to assistance to foreign atomic energy activities);

(4) Nuclear facilities, equipment, and material covered by part 110 of title 10, Code of Federal Regulations (relating to export and import of nuclear equipment and material);

(5) Select agents and toxins covered by part 331 of title 7, Code of Federal Regulations, part 121 of title 9 of such Code, or part 73 of title 42 of such Code; or

(6) Emerging and foundational technologies controlled pursuant to section 1758 of the Export Control Reform Act of 2018 (50 U.S.C. 4817).

Interconnection arrangements means arrangements governing the physical connection of two or more networks to allow the use of another's network to hand off traffic where it is ultimately delivered (e.g., connection

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

of a customer of telephone provider A to a customer of telephone company B) or sharing data and other information resources.

Reasonable inquiry means an inquiry designed to uncover any information in the entity's possession about the identity of the producer or provider of covered telecommunications equipment or services used by the entity that excludes the need to include an internal or third-party audit.

Roaming means cellular communications services (e.g., voice, video, data) received from a visited network when unable to connect to the facilities of the home network either because signal coverage is too weak or because traffic is too high.

Substantial or essential component means any component necessary for the proper function or performance of a piece of equipment, system, or service.

(b) Prohibition.

(1) Section 889(a)(1)(A) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019 (Pub. L.

115-232) prohibits the head of an executive agency on or after August 13, 2019, from procuring or obtaining, or extending or renewing a contract to procure or obtain, any equipment, system, or service that uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system. The Contractor is prohibited from providing to the Government any equipment, system, or service that uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system, unless an exception at paragraph (c) of this clause applies or the covered telecommunication equipment or services are covered by a waiver described in

FAR 4.2104.

(2) Section 889(a)(1)(B) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019 (Pub. L. 115-232) prohibits the head of an executive agency on or after August 13, 2020, from entering into a contract, or extending or renewing a contract, with an entity that uses any equipment, system, or service that uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system, unless an exception at paragraph (c) of this clause applies or the covered telecommunication equipment or services are covered by a waiver described in FAR 4.2104. This prohibition applies to the use of covered telecommunications equipment or services, regardless of whether that use is in performance of work under a Federal contract.

(c) Exceptions. This clause does not prohibit contractors from providing—

(1) A service that connects to the facilities of a third-party, such as backhaul, roaming, or interconnection arrangements; or

(2) Telecommunications equipment that cannot route or redirect user data traffic or permit visibility into any user data or packets that such equipment transmits or otherwise handles.

(d) Reporting requirement.

(1) In the event the Contractor identifies covered telecommunications equipment or services used as a substantial or essential component of any system, or as critical technology as part of any system, during contract performance, or the Contractor is notified of such by a subcontractor at any tier or by any other source, the Contractor shall report the information in paragraph (d)(2) of this clause to the Contracting Officer, unless elsewhere in this contract are established procedures for reporting the information; in the case of the Department of Defense, the Contractor shall report to the website at https://dibnet.dod.mil. For indefinite delivery contracts, the Contractor shall report to the Contracting Officer for the indefinite delivery contract and the Contracting Officer(s) for any affected order or, in the case of the Department of Defense, identify both the indefinite delivery contract and any affected orders in the report provided at https://dibnet.dod.mil.

(2) The Contractor shall report the following information pursuant to paragraph (d)(1) of this clause

(i) Within one business day from the date of such identification or notification: the contract number; the order number(s), if applicable; supplier name; supplier unique entity identifier (if known); supplier Commercial and Government Entity (CAGE) code (if known); brand; model number (original equipment manufacturer number, manufacturer part number, or wholesaler number); item description; and any readily available information about mitigation actions undertaken or recommended.

(ii) Within 10 business days of submitting the information in paragraph (d)(2)(i) of this clause: any further available information about mitigation actions undertaken or recommended. In addition, the Contractor https://www.acquisition.gov/far/part-4#FAR_4_2104 https://www.acquisition.gov/far/part-4#FAR_4_2104 https://dibnet.dod.mil/ https://dibnet.dod.mil/

ATTACHMENT 2 SAMPLE TASK ORDER DOMAIN 2

shall describe the efforts it undertook to prevent use or submission of covered telecommunications equipment or services, and any additional efforts that will be incorporated to prevent future use or submission of covered telecommunications equipment or services.

(e) Subcontracts. The Contractor shall insert the substance of this clause, including this paragraph (e) and excluding paragraph (b)(2), in all subcontracts and other contractual instruments, including subcontracts for the acquisition of commercial items.

(End of clause)

FAR 52.217-8 Option to Extend Services (Nov 1999) The Government may require continued performance of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by written notice to the Contractor within 10 days prior to expiration of the contract.

FAR 52.227-14 Rights in Data-General, Alternate IV (Dec 2007) As prescribed in 27.409(b) (5), substitute the following paragraph (c) (1) for paragraph (c) (1) of the basic clause:

(c) Copyright—(1) Data first produced in the performance of the contract. Except as otherwise specifically provided in this contract, the Offeror may assert copyright in any data first produced in the performance of this contract. When asserting copyright, the Offeror shall affix the applicable copyright notice of 17 U.S.C. 401 or 402, and an acknowledgment of Government sponsorship (including contract number), to the data when such data are delivered to the Government, as well as when the data are published or deposited for registration as a published work in the U.S. Copyright Office. For data other than computer software, the Offeror grants to the Government, and others acting on its behalf, a paid-up, nonexclusive, irrevocable, worldwide license for all such data to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government. For computer software, the Offeror grants to the Government and others acting on its behalf, a paid-up, nonexclusive, irrevocable, worldwide license for all such computer software to reproduce, prepare derivative works, and perform publicly and display publicly (but not to distribute copies to the public), by or on behalf of the Government.

HHSAR 352.224-70, Privacy Act (Dec 2015)…